Table 1: Patient demographics.

Stage of therapyIdentityAge Male/femaleMethadone dose (mg)

TitrationT132F95
T223F65
T337F55
T433M40
T520M60

Harm reductionHR137F90
HR228M85
HR323F150
HR423F150

Long termLT135M95
LT233M150
LT336F40
LT444F90
LT530M105
LT651M85
LT734M150
LT842M50
LT934M150
LT1031M200
LT1130M90